News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare Disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Chikungunya infection in children masquerades as SJS-TEN
MDedge Family Medicine
FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Family Medicine
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Family Medicine
Intrauterine therapy showed promise in XLHED
MDedge Family Medicine
Low incidence of HS in children does not diminish importance of early diagnosis
MDedge Family Medicine
VIDEO: Few transgender patients desire care in a transgender-only clinic
MDedge Family Medicine
Collagen remodeling observed after laser treatment in EB patient
MDedge Family Medicine
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Family Medicine
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Family Medicine
RFPs Available for the Study of Three Rare Diseases
MDedge Family Medicine